Rayyan vs Covidence vs AI-first screening tools

1. The appeal of manual-first platforms

Rayyan and Covidence are the traditional giants in the systematic review space. They excel at collaborative manual screening, blind dual review, and institutional governance. These platforms are proven choices if your university already provides licenses and your entire team is fully trained on how to use them.

2. Where manual tools slow your research down

Neither Rayyan nor Covidence was built to be an AI-native workspace. Their artificial intelligence features mostly focus on reordering your list or highlighting specific keywords. This means you must still read every single abstract yourself. Additionally, essential tasks like protocol drafting and search string generation must happen entirely outside the software.

3. The advantage of an AI-first workspace

Modern AI screening tools take a completely different approach. Meta-analysis360 embeds Generative AI across your entire workflow: planning, protocol creation, search strategy generation, and abstract screening. You calibrate the model upfront to understand your inclusion criteria. The AI then provides "Include", "Exclude", or "Maybe" suggestions alongside a detailed written rationale for every paper. You simply verify the decisions.

4. Making the right choice for your team

You should pick Rayyan or Covidence if your institution mandates them or if your methodology requires 100% manual screening from start to finish. You should choose an AI-first workspace if your goal is to finish the title and abstract screening phase weeks faster while still keeping strict human oversight on every final decision.

For more details, explore our specific comparison pages for Rayyan and Covidence, or read our full automated meta-analysis tools roundup.